{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:03:45Z","timestamp":1749873825305,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018786","name":"Al-Zaytoonah University of Jordan","doi-asserted-by":"publisher","award":["2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28"],"award-info":[{"award-number":["2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28","2025-2024\/06\/28"]}],"id":[{"id":"10.13039\/501100018786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02624-4","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:52:40Z","timestamp":1749793960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of interleukins 38 and 1 Beta gene expression by N-(4-benzoylphenyl)-5-nitrofuran-2-carboxamide in Triton WR-1339 induced hyperlipidemic rats"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-279X","authenticated-orcid":false,"given":"Mohammad","family":"Alwahsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-3303","authenticated-orcid":false,"given":"Lama","family":"Hamadneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhair","family":"Hikmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmeen Zaid","family":"Al-Kilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Al-Kouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahaf","family":"Alejel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Al-Hiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa R.","family":"Althaher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basmah","family":"Al-Jammal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buthaina","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Al-Qirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2624_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2012","unstructured":"Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2012;40:195.","journal-title":"Prim Care"},{"key":"2624_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.7150\/ijms.43981","volume":"17","author":"H Liu","year":"2020","unstructured":"Liu H, Li Y, Lin N, Dong X, Li W, Deng Y. Interleukin-1\u03b2 promotes Ox-LDL uptake by human glomerular mesangial cells via LOX-1. Int J Med Sci. 2020;17:1056.","journal-title":"Int J Med Sci"},{"key":"2624_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/biomedicines12071504","volume":"12","author":"Q Zong","year":"2024","unstructured":"Zong Q, He C, Long B, Huang Q, Chen Y, Li Y, Dang Y, Cai C. Targeted delivery of nanoparticles to blood vessels for the treatment of atherosclerosis. Biomedicines. 2024;12:1504.","journal-title":"Biomedicines"},{"key":"2624_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1177\/2047487318773384","volume":"25","author":"J Tu\u00f1\u00f3n","year":"2018","unstructured":"Tu\u00f1\u00f3n J, B\u00e4ck M, Badim\u00f3n L, Bochaton-Piallat ML, Cariou B, Daemen MJ, et al. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: translating experimental targets into clinical practice. Eur J Prev Cardiol. 2018;25:948\u201355.","journal-title":"Eur J Prev Cardiol"},{"key":"2624_CR5","doi-asserted-by":"publisher","first-page":"1700204","DOI":"10.1002\/ardp.201700204","volume":"350","author":"R Abu Khalaf","year":"2017","unstructured":"Abu Khalaf R, Sabbah D, Al-Shalabi E, Bishtawi S, Albadawi G, Abu Sheikha G. Synthesis, biological evaluation, and molecular modeling study of substituted benzyl benzamides as CETP inhibitors. Arch Pharm. 2017;350:1700204.","journal-title":"Arch Pharm"},{"key":"2624_CR6","first-page":"927","volume":"5","author":"M Rafieian-Kopaei","year":"2014","unstructured":"Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927.","journal-title":"Int J Prev Med"},{"key":"2624_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","volume":"95","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Mechanisms of foam cell formation in atherosclerosis. J Mol Med. 2017;95:1153\u201365.","journal-title":"J Mol Med"},{"key":"2624_CR8","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.2174\/0929867322666150520095008","volume":"22","author":"A Papapanagiotou","year":"2015","unstructured":"Papapanagiotou A, Siasos G, Kassi EN, Gargalionis AG, Papavassiliou A. Novel inflammatory markers in hyperlipidemia: clinical implications. Curr Med Chem. 2015;22:2727\u201343.","journal-title":"Curr Med Chem"},{"key":"2624_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cca.2022.09.017","volume":"536","author":"XH Zhang","year":"2022","unstructured":"Zhang XH, Li Y, Zhou L, Tian GP. Interleukin-38 in atherosclerosis. Clin Chim Acta. 2022;536:86\u201393.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2624_CR10","first-page":"376","volume":"23","author":"L Jin","year":"2023","unstructured":"Jin L, Hua H, Ji Y, Jia Z, Peng M, Huang S. Anti-inflammatory role of fenofibrate in treating diseases. Biomol Biomed. 2023;23(3):376\u201391.","journal-title":"Biomol Biomed"},{"key":"2624_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.toxrep.2014.02.003","volume":"1","author":"MS Zarzecki","year":"2014","unstructured":"Zarzecki MS, Araujo SM, Bortolotto VC, de Paula MT, Jesse CR, Prigol M. Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL\/6 mice. Toxicol Rep. 2014;1:200\u20138.","journal-title":"Toxicol Rep"},{"key":"2624_CR12","doi-asserted-by":"publisher","first-page":"22193","DOI":"10.1039\/D3RA03581F","volume":"13","author":"B Al-Jammal","year":"2023","unstructured":"Al-Jammal B, Hussein B, Al-Hiari Y, Al-Qirim T, Al-Najdawi M, Hamadneh L, et al. Synthesis of microwave-assisted carboxamides in Triton WR-1339-induced hyperlipidemic rats: possible hypolipidemic heterocyclic compounds. RSC Adv. 2023;13:22193\u2013204.","journal-title":"RSC Adv"},{"key":"2624_CR13","doi-asserted-by":"crossref","unstructured":"Hussein B, Alwahsh M, Al-Hiari Y, Bourghli L, Al-Jammal B, Al-Qirim T et al. Substituted furan-carboxamide and schiff base derivatives as potential hypolipidemic compounds: evaluation in Triton WR-1339 hyperlipidemic rat model. Med Chem Res. 2024:1992.","DOI":"10.1007\/s00044-024-03300-5"},{"key":"2624_CR14","first-page":"64","volume":"14","author":"T Al-Qirim","year":"2024","unstructured":"Al-Qirim T, Al Bawab AQ, Al-Hiari Y, Ahmad NH, Alwahsh M, Al-Kouz S, et al. Synthesis and lipid-lowering properties of novel N-(4-benzoylphenyl) pyrrole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats. J Appl Pharm Sci. 2024;14:64\u201370.","journal-title":"J Appl Pharm Sci"},{"key":"2624_CR15","doi-asserted-by":"publisher","first-page":"478973","DOI":"10.1155\/2014\/478973","volume":"1","author":"K Venkadeswaran","year":"2014","unstructured":"Venkadeswaran K, Muralidharan AR, Annadurai T, Ruban VV, Sundararajan M, Anandhi R, et al. Antihypercholesterolemic and antioxidative potential of an extract of the plant, piper betle, and its active constituent, eugenol, in triton WR-1339-induced hypercholesterolemia in experimental rats. Evid Based Complement Alternat Med. 2014;1:478973.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2624_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1515\/znc-2010-5-601","volume":"65","author":"M Shahwan","year":"2010","unstructured":"Shahwan M, Shattat G, Al-Qirim T, Sheikha GA, Al-Hiari Y, El-Huneidi W, et al. Synthesis and pharmacological evaluation of novel substituted and unsubstituted N-(benzoylphenyl)-1H-indole-2-carboxamides as potent antihypertriglyceridemic agents. Z Naturforsch C J Biosci. 2010;65:309\u201316.","journal-title":"Z Naturforsch C J Biosci"},{"key":"2624_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04174-z","author":"S Hikmat","year":"2025","unstructured":"Hikmat S, Hasan A, Hamadneh L, et al. Novel carboxamide derivatives increase lipoprotein lipase gene expression in endothelial and adipose tissues of triton WR- 1339 induced hyperlipidemic rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-04174-z","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2624_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-017-2983-3","volume":"431","author":"L Hamadneh","year":"2017","unstructured":"Hamadneh L, Al-Essa L, Hikmat S, Al-Qirim T, Abu Sheikha G, Al-Hiari Y, et al. N-(3-benzoylphenyl)-1H-indole-2-carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model. Mol Cell Biochem. 2017;431:133\u20138.","journal-title":"Mol Cell Biochem"},{"key":"2624_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s43044-022-00317-2","volume":"74","author":"S Thupakula","year":"2022","unstructured":"Thupakula S, Nimmala SS, Ravula H, Chekuri S, Padiya R. Emerging biomarkers for the detection of cardiovascular diseases. Egypt Heart J. 2022;74:77.","journal-title":"Egypt Heart J"},{"key":"2624_CR20","doi-asserted-by":"crossref","unstructured":"Mai W, Liao Y. Targeting IL-1\u03b2 in the treatment of atherosclerosis. Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.589654"},{"key":"2624_CR21","first-page":"304","volume":"4","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang F, Wang Y, Gister\u00e5 A, Roy J, Paulsson-Berne G, et al. Inflammasome-driven interleukin-1\u03b1 and interleukin-1\u03b2 production in atherosclerotic plaques relates to hyperlipidemia and plaque complexity. JACC: Basic Transl Sci. 2019;4:304\u201317.","journal-title":"JACC: Basic Transl Sci"},{"key":"2624_CR22","doi-asserted-by":"crossref","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9.","DOI":"10.3389\/fimmu.2018.00754"},{"key":"2624_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0002-9149(03)00774-4","volume":"92","author":"PM Ridker","year":"2003","unstructured":"Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92:17\u201322.","journal-title":"Am J Cardiol"},{"key":"2624_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41419-020-2264-z","volume":"11","author":"S Zhao","year":"2020","unstructured":"Zhao S, Jiang J, Jing Y, Liu W, Yang X, Hou X, et al. The concentration of tumor necrosis factor-\u03b1 determines its protective or damaging effect on liver injury by regulating Yap activity. Cell Death Dis. 2020;11:70.","journal-title":"Cell Death Dis"},{"key":"2624_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.34172\/jcvtr.2020.07","volume":"12","author":"A Khorrami","year":"2020","unstructured":"Khorrami A, Ziaee M, Rameshrad M, Nakhlband A, Maleki-Dizaji N, Garjani A. Oxidized cholesterol exacerbates toll-like receptor 4 expression and activity in the hearts of rats with myocardial infarction. J Cardiovasc Thorac Res. 2020;12:43.","journal-title":"J Cardiovasc Thorac Res"},{"key":"2624_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1134\/S0006297916110134","volume":"81","author":"AR Fatkhullina","year":"2016","unstructured":"Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of atherosclerosis. Biochem (Mosc). 2016;81:1358\u201370.","journal-title":"Biochem (Mosc)"},{"key":"2624_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","volume":"174","author":"M Heydtmann","year":"2005","unstructured":"Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol. 2005;174:1055\u201362.","journal-title":"J Immunol"},{"key":"2624_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5301\/jsrd.5000265","volume":"2","author":"E Choy","year":"2017","unstructured":"Choy E, Rose-John S. Interleukin-6 as a multifunctional regulator: inflammation, immune response, and fibrosis. J Scleroderma Relat Disord. 2017;2:S1\u20135.","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"2624_CR29","first-page":"14","volume":"12","author":"AB Reiss","year":"2017","unstructured":"Reiss AB, Siegart NM, De Leon J. Interleukin-6 in atherosclerosis: atherogenic or atheroprotective? Clin Lipidol. 2017;12(1):14\u201323.","journal-title":"Clin Lipidol"},{"key":"2624_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/medicina58050624","volume":"58","author":"M Basiak","year":"2022","unstructured":"Basiak M, Kosowski M, Hachula M, Okopien B. Plasma concentrations of cytokines in patients with combined hyperlipidemia and atherosclerotic plaque before treatment initiation\u2014a pilot study. Medicina. 2022;58:624.","journal-title":"Medicina"},{"key":"2624_CR31","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.2174\/138161211798764780","volume":"17","author":"G Siasos","year":"2011","unstructured":"Siasos G, Tousoulis D, Oikonomou E, Zaromitidou M, Stefanadis C, Papavassiliou AG. Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. Curr Pharm Des. 2011;17:4132\u201346.","journal-title":"Curr Pharm Des"},{"key":"2624_CR32","doi-asserted-by":"crossref","unstructured":"Teufel LU, de Graaf DM, Netea MG, Dinarello CA, Joosten LA, Arts RJ. Circulating interleukin-38 concentrations in healthy adults. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.964365"},{"key":"2624_CR33","doi-asserted-by":"publisher","first-page":"108876","DOI":"10.1016\/j.intimp.2022.108876","volume":"108","author":"M Lai","year":"2022","unstructured":"Lai M, Peng H, Wu X, Chen X, Wang B, Su X. IL-38 in modulating hyperlipidemia and its related cardiovascular diseases. Int Immunopharmacol. 2022;108:108876.","journal-title":"Int Immunopharmacol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02624-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:52:43Z","timestamp":1749793963000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02624-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Ethical Committee of Al-Zaytoonah University of Jordan (approval reference number 22\/05\/2021\u20132022) The study complied with the relevant ethical regulations pertaining to animal research, and all laboratory animals were cared for and used according to institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and agreed with the submission of the manuscript to Lipids in Health and Disease.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}